Global Ophthalmic Drugs Market 2019 – 2025 – By Type, Component, Industry, Region
May 20, 2019
WiseGuyReports.Com Publish a New Market Research Report On –“Ophthalmic Drugs Market 2018 – Global Sales,Price,Revenue,Gross Margin and Market Share”.
pune, india - May 20, 2019 /MarketersMedia/ —
Report Description:
Ophthalmology is a wide therapy area that consists of almost 100 disorders related with the eyes and visual system, containing such diseases as glaucoma, age-related macular degeneration (AMD), diabetic retinopathy (DR), dry eye syndrome (DES), and diabetic macular edema (DME). Various disorders are progressive, and if left untreated can lead to severe visual impairment or even blindness.
Demand Scenario
The global ophthalmic drugs market was USD 27.55 billion in 2018 and is estimated to reach USD 36.93 billion by 2025 at a CAGR of 4.27% during the forecast period
Growth by Region
North America dominated the ophthalmic drugs market owing to the rising patient population, growing prevalence of eye diseases, well-developed technology, high healthcare expenditure, and the presence of the leading players. The government support towards research and development expenditure, growing competition among marketers, and amendments in reimbursement policies in healthcare will drive the European market. However, Asia Pacific will be the fastest growing market due to a huge patient pool, rising demand, and development of the healthcare technology.
Request Free Sample Report at:https://www.wiseguyreports.com/sample-request/3981804-global-ophthalmic-drugs-market-by-indication-type-dosage
Drivers and Restraints
The development of effective ophthalmic is vital in the current scenario, due to rise in incidence of ophthalmic disorders such as glaucoma, cataract, and other common eye infections. Market players focus on invention of novel approaches for the development of ophthalmic drugs over the years, including small molecule, biologics, and recombinant technologies, hence driving the growth of ophthalmic drugs market. The huge cost associated with a diagnosis of eye diseases, side effects of available treatment options, lack of healthcare insurance, and poor healthcare system in low and middle-income countries are affecting the growth of the market.
Industry Trends and Updates
In 2017, Spark Therapeutics gained FDA approval for its orphan drug Voretigene Neparvovec, which is currently under development for retinitis pigmentosa and leber congenital amaurosis. In November 2017, Bausch & Lomb, a U.S.-based company, obtained the FDA approval for Vyzulta (latanoprostene bunod ophthalmic solution) which is designed for the decrease of intraocular pressure in patients with glaucoma or ocular hypertension. Pharmaceuticals has also obtained FDA approval for the treatment of glaucoma or ocular hypertension.
We also can offer customized report to fulfill special requirements of our clients. Regional and Countries report can be provided as well.
View Detailed Report at :https://www.wiseguyreports.com/reports/3981804-global-ophthalmic-drugs-market-by-indication-type-dosage
Global Ophthalmic Drugs Market – by Indication, Type, Dosage Form, Technology, Distribution Channel, Therapeutic Class, Region - Market Size, Demand Forecasts, Company Profiles, Industry Trends and Updates (2018 - 2025)
1. Research Methodology
2. Executive Summary
3. Market Overview
3.1. Definition
3.2. Industry Value Chain Analysis
3.3. Porter's 5 Forces
3.4. Regulations
4. Market Dynamics
4.1. Introduction
4.2. Drivers
4.3. Constraints
4.4. Trends
……
10. Global Ophthalmic Drugs Market Segmentation, Forecasts and Trends - by Therapeutic Class
10.1. Anti-glaucoma
10.2. Anti-infection
10.3. Anti-inflammatory
10.4. Anti-allergy
11. Global Ophthalmic Drugs Market Segmentation, Forecasts and Trends - by Region
11.1. North America
11.1.1. U.S.
11.1.2. Canada
11.1.3. Mexico
11.2. Europe
11.2.1. Germany
11.2.2. France
11.2.3. UK
11.2.4. Italy
Continued…
About Us:
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the global.
Contact Us:
NORAH TRENT
[email protected]
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)
Contact Info:
Name: NORAH TRENT
Organization: WISEGUY RESEARCH CONSULTANTS PVT LTD
Website: https://www.wiseguyreports.com
Source URL: https://marketersmedia.com/global-ophthalmic-drugs-market-2019-2025-by-type-component-industry-region/514611
Source: MarketersMedia
Release ID: 514611
More News
Docker Fixes Critical Two-Year-Old Hub Flaw That Let One User Push Images as Another
A flaw in Docker Hub, the registry where container images are published and downloaded, let one user push, pull, or delete images as another user. Docker fixed the flaw on September 30 and says it found no evidence that anyone exploited it. The flaw was in the feature that converts a personal account into an organization, Docker said in a security advisory on October 12.
Attacker Chains Three Ivanti Connect Secure Zero-Days for Root Access, Only Two Patched So Far
An attacker chained three zero-day flaws in Ivanti Connect Secure, a VPN appliance, to run commands as root without logging in, security firm Volexity said on October 13. Ivanti has released fixes for two of the flaws and told customers on affected versions to "act immediately." A fix for the third is still pending, according to Volexity. Volexity, which reported the flaws to Ivanti,
SAP Discloses Critical CVSS 10 Flaw in Cloud SDK for Python Allowing OAuth2 Credential Theft
A flaw in SAP's Cloud SDK for Python can send an application's OAuth2 client credentials to a server an attacker controls, SAP said in a security advisory on October 13. The flaw affects multi-tenant applications on SAP Business Technology Platform (BTP) that use the SDK, SAP's official Python client for BTP services. An attacker must be able to control the tenant subdomain,
Apple Introduces HomeView, a $299 Tablet for the Home
Apple unveiled the device as it continues its foray into artificial intelligence and tries to prove it can still innovate.
Will We Ever Understand Dementia?
Since the days of Dr. Alzheimer himself, there has been a dream that severe senility might have an explanation — and a cure. The search for both has never been more urgent.
GitHub Tightens npm Publishing After Flaw Left 1,500+ Packages Vulnerable to Hijacking
GitHub has taken the step of expiring unvalidated npm trusted publishing configurations 48 hours after creation after researchers found that it was possible for an attacker to push new versions of a different user's package without having to steal their credentials. "Your configuration becomes validated and exempt from expiry after its first successful publish," the Microsoft-owned subsidiary
Bumble bought for $1.3bn in 'bet on the future of humanity'
The dating app which recently ditched its "women-first" chat rule has been bought by an investment firm.
Inside a Quebec cranberry bog
Quebec is the largest producer of organic cranberries in the world and leads the country in production. The operations are mainly in the Centre-du-Québec region, and the province produces more than 250 million pounds annually.
Apple Welcome Home Event 2026: HomeView Smart display, HomePod Mini 2, Apple TV 4K and more launched
Apple unveiled its HomeView smart home hub, updated HomePod Mini 2, new Apple TV 4K and Apple Home Collection at its ‘Welcome Home’ event on October 13, 2026. The HomeView features a touchscreen, AI-powered Siri, personalised interfaces and smart home controls, with a starting price of $299.
Xandr Fined a Record €8.6 Million for Relaying Grindr Data Revealing Sexual Orientation
The Norwegian Data Protection Authority (DPA) has fined Xandr, an advertising unit owned by Microsoft, €8.6 million ($9.62 million) for illegally relaying Grindr users' sensitive data to advertisers. The administrative penalty is the largest issued by the data protection watchdog, arguing the case merited a high fine because of the "very serious" nature of the breach. The infringements
Huawei, once hobbled by US sanctions, passes 100 million Kirin chip milestone
Huawei Technologies has shipped more than 100 million devices powered by its Kirin processors since 2023, when it returned to the smartphone market with a new generation of premium handsets. The company says testing of its next-generation Kirin 2027 chip is also progressing in line with expectations. The company disclosed the figure on Tuesday as it unveiled new details about its flagship Kirin 9050 series, the first mass-produced chip using its proprietary LogicFolding architecture, developed...
I was secretly poisoned by my husband and died. Then I met Jesus and made a shocking discovery in heaven
A wife and mother claims she had a life-changing meeting with Jesus in the afterlife while her husband attempted to kill her before he could be cut out of her life insurance policy.
Recommended
China is bringing car production to EU
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.